FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to obstetrics, as well as to scientific research of pathological physiology. In pregnant women with a moderate course of COVID-19 in the third trimester, content of 8-isoprostane, pg/ml, and 12-hydroxyeicosatetraenoic acid, ng/ml, are measured in peripheral blood by enzyme immunoassay. Premature onset of labour is predicted by calculating a prognostic index (PI): PI = -7.607 + 0.022 × 8-isoprostane + 0.309 × 12-hydroxyeicosatetraenoic acid, where PI is a discriminant function, the boundary value of which is 3.244. If PI is equal to or greater than the boundary value, premature onset of labour is predicted. If PI is less than the boundary value, the absence of premature onset of labour in women with moderate course of COVID-19 in the third trimester is predicted.
EFFECT: method enables to predict premature onset of labour in women with moderate course of COVID-19 in the third trimester.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF THREATENED MISCARRIAGE BY DETERMINING BLOOD SERUM OF 8-ISOPROSTANE AND 15-HYDROXYEICOSATETRAENOIC ACID IN WOMEN WITH COVID-19 IN THE FIRST TRIMESTER | 2024 |
|
RU2821133C1 |
| METHOD OF PREDICTING PRETERM LABOR IN WOMEN WITH PNEUMONIA IN THE THIRD TRIMESTER CAUSED BY SARS-CoV-2 | 2023 |
|
RU2801031C1 |
| METHOD FOR PREDICTING ANEMIA IN PREGNANT WOMEN WITH COVID-19 PNEUMONIA | 2022 |
|
RU2772906C1 |
| METHOD OF EARLY PREDICTION OF MISCARRIAGE BY ASSESSING INTERLEUKIN 1Β AND PROSTAGLANDIN E2 IN THE BLOOD SERUM OF PREGNANT WOMEN WITH EXACERBATION OF CYTOMEGALOVIRUS INFECTION | 2023 |
|
RU2804278C1 |
| METHOD OF PREDICTING MISCARRIAGE IN THE FIRST TRIMESTER BY ASSESSING CYCLOOXYGENASE 2 AND PROSTAGLANDIN E2 IN THE PERIPHERAL BLOOD OF PREGNANT WOMEN DURING EXACERBATION OF CYTOMEGALOVIRUS INFECTION | 2023 |
|
RU2800080C1 |
| METHOD FOR PREDICTION OF SPONTANEOUS MISCARRIAGE AFTER SUFFERING NEW CORONAVIRUS INFECTION (NCOV) OF MILD AND MODERATE FORM | 2024 |
|
RU2816804C1 |
| METHOD FOR ASSESSING RISK OF PERINATAL COMPLICATIONS ASSOCIATED WITH INFECTION CAUSED BY SARS-COV-2 IN THIRD TRIMESTER OF PREGNANCY | 2023 |
|
RU2820005C1 |
| METHOD FOR PREDICTING THE THREAT OF MISCARRIAGE DURING REACTIVATION OF LATENT CYTOMEGALOVIRUS INFECTION BY DETERMINING ESTRADIOL AND ESTROGEN RECEPTOR ALPHA IN BLOOD SERUM | 2021 |
|
RU2762485C1 |
| METHOD OF PREDICTING MISCARRIAGE BY ASSESSING VASCULAR ENDOTHELIAL GROWTH FACTOR AND PROSTAGLANDIN F2Α IN THE PERIPHERAL BLOOD OF PREGNANT WOMEN DURING EXACERBATION OF CYTOMEGALOVIRUS INFECTION IN THE FIRST TRIMESTER | 2023 |
|
RU2800311C1 |
| METHOD OF PREDICTING THE RISK OF DEATH FROM COVID-19 IN YOUNG PATIENTS | 2023 |
|
RU2803002C1 |
